US Clinics Marketing Unproven and Unlicensed Adipose-Derived Autologous Stem Cell Interventions

    May 2015 in “ Regenerative Medicine ”
    Leigh Turner
    Studysummary This commentary explores the marketing of unproven and unlicensed adipose-derived stem cell treatments in US clinics, highlighting concerns about patient safety and regulatory challenges.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on futuremedicine.com →
    Discuss this study in the Community →